电子脊椎植入物 让截瘫病人重新活动双腿

2017-04-07 佚名 腾讯数码

通常来说,脊椎神经受损后的状态是不可逆的,也就是我们常说的瘫痪或是高位截瘫。然而在传感器、植入物技术不断发展的情况下,越来越多科学家、医学家开始探索让瘫痪患者重新站起来、甚至走路的方法。近日,美国梅奥诊所发布了一份报告,描述了一种新型脊椎植入物技术,可以让截瘫病人重新活动双腿,可谓是一项重大的医学突破。该电子植入物需要植入到患者脊椎附近,通过电极适当刺激脊椎,经过一段时间的适应和复健治疗,使患者脊

通常来说,脊椎神经受损后的状态是不可逆的,也就是我们常说的瘫痪或是高位截瘫。然而在传感器、植入物技术不断发展的情况下,越来越多科学家、医学家开始探索让瘫痪患者重新站起来、甚至走路的方法。

近日,美国梅奥诊所发布了一份报告,描述了一种新型脊椎植入物技术,可以让截瘫病人重新活动双腿,可谓是一项重大的医学突破。

该电子植入物需要植入到患者脊椎附近,通过电极适当刺激脊椎,经过一段时间的适应和复健治疗,使患者脊椎功能部分恢复,虽然目前临床实验并没有患者能够真正像普通人那样自由走动,但已经可以移动双腿、并使用拐杖行走。

临床实验患者是一名26岁的男子,三年前因为意外导致脊椎损伤,完全无法移动躯干中下部分,也就是完全丧失了下肢机能。而在接受了梅奥诊所的电子脊椎植入物移植、并进行22周物理治疗后,他已经能够移动双腿(仍需使用遥控器控制植入物),甚至重新开车。

当然,该技术仍处于初始阶段,仍有很长的路要走。不过,这项研究让人们看到了脊椎损伤完全恢复的希望,或许未来几十年就能实现。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1490878, encodeId=1ef014908e837, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520354, encodeId=ee02152035406, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630491, encodeId=8eab1630491ab, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1490878, encodeId=1ef014908e837, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520354, encodeId=ee02152035406, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630491, encodeId=8eab1630491ab, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
    2017-04-09 jiyangfei
  3. [GetPortalCommentsPageByObjectIdResponse(id=1490878, encodeId=1ef014908e837, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520354, encodeId=ee02152035406, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630491, encodeId=8eab1630491ab, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sun Apr 09 09:34:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
    2017-04-09 neizongke